메뉴 건너뛰기




Volumn 3, Issue 1, 2009, Pages 199-210

Management of ocular inflammation and pain following cataract surgery: Focus on bromfenac ophthalmic solution

Author keywords

Bromfenac; Ocular inflammation; Ophthalmic NSAIDs

Indexed keywords

AMFENAC; BROMFENAC; BRONUCK; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; INDOMETACIN; KETOROLAC; KETOROLAC TROMETAMOL; NEPAFENAC; NONSTEROID ANTIINFLAMMATORY AGENT; OFLOXACIN; PRANOPROFEN; PREDNISOLONE; STEROID; UNCLASSIFIED DRUG;

EID: 77949451059     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/opth.s4806     Document Type: Review
Times cited : (71)

References (84)
  • 2
    • 0033957949 scopus 로고    scopus 로고
    • Control of intraocular inflammation associated with cataract surgery
    • McColgin AZ, Heier JS. Control of intraocular inflammation associated with cataract surgery. Curr Opin Ophthalmol. 2000;11:3-6.
    • (2000) Curr Opin Ophthalmol , vol.11 , pp. 3-6
    • McColgin, A.Z.1    Heier, J.S.2
  • 3
    • 30344481336 scopus 로고    scopus 로고
    • An update on the use of ophthalmic ketorolac tromethamine 0.4%
    • Perry HD, Donnenfeld ED. An update on the use of ophthalmic ketorolac tromethamine 0.4%. Expert Opin Pharmacother. 2006;7(1):99-107.
    • (2006) Expert Opin Pharmacother , vol.7 , Issue.1 , pp. 99-107
    • Perry, H.D.1    Donnenfeld, E.D.2
  • 4
    • 0027792544 scopus 로고
    • Non-steroidal anti-inflammatory drug and endotoxin induced unveitis
    • Chang JH, Chung H. Non-steroidal anti-inflammatory drug and endotoxin induced unveitis. Korean J Ophthalmol. 1993;7:35-42.
    • (1993) Korean J Ophthalmol , vol.7 , pp. 35-42
    • Chang, J.H.1    Chung, H.2
  • 5
    • 0008166911 scopus 로고
    • Steroids as anti-inflammatory agents
    • Sears ML, editor. Springer-Verlag, New York;
    • Polansky JR, Weinreb RN. Steroids as anti-inflammatory agents. In: Pharmacology of the Eye. Sears ML, editor. Springer-Verlag, New York; 1984. p. 460-538.
    • (1984) Pharmacology of the Eye , pp. 460-538
    • Polansky, J.R.1    Weinreb, R.N.2
  • 6
    • 0002953558 scopus 로고    scopus 로고
    • Lipid-derived autacoids: Eicosanoids and platelet-activating factor
    • editors, 9th ed. New York, NY: McGraw-NetHill;
    • Campbell WB, Halushka PV. Lipid-derived autacoids: eicosanoids and platelet-activating factor: In: Hardman JG, Limbird LE, Molinoff PB, et al. editors. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-NetHill; 1996. p. 601-616.
    • (1996) Goodman and Gilman's The Pharmacological Basis of Therapeutics , pp. 601-616
    • Campbell, W.B.1    Halushka, P.V.2
  • 7
    • 33750345890 scopus 로고    scopus 로고
    • Global experience with Xibrom (bromfenac ophthalmic solution) 0.09%: The first twice-daily ophthalmic nonsteroidal anti-inflammatory drug
    • Donnenfeld ED, Donnenfeld A. Global experience with Xibrom (bromfenac ophthalmic solution) 0.09%: the first twice-daily ophthalmic nonsteroidal anti-inflammatory drug. Int Ophthalmol Clin. 2006;46(4):21-40.
    • (2006) Int Ophthalmol Clin , vol.46 , Issue.4 , pp. 21-40
    • Donnenfeld, E.D.1    Donnenfeld, A.2
  • 8
    • 6344260351 scopus 로고    scopus 로고
    • Involvement of cyclooxygenase-2 in rat models of conjunctivitis
    • Oka T, Shearer TR, Azuma M. Involvement of cyclooxygenase-2 in rat models of conjunctivitis. Curr Eye Res. 2004;29:27-34.
    • (2004) Curr Eye Res , vol.29 , pp. 27-34
    • Oka, T.1    Shearer, T.R.2    Azuma, M.3
  • 9
    • 0036192290 scopus 로고    scopus 로고
    • Locally administered ocular corticosteroids: Benefits and risks
    • McGhee CN, Dean S, Danesh-Meyer H: Locally administered ocular corticosteroids: benefits and risks. Drug Saf. 2002;25:33-55.
    • (2002) Drug Saf , vol.25 , pp. 33-55
    • McGhee, C.N.1    Dean, S.2    Danesh-Meyer, H.3
  • 10
    • 0029871305 scopus 로고    scopus 로고
    • The role of non-steroidal anti-inflammatory drugs in ocular inflammation
    • Samiy N, Foster CS. The role of non-steroidal anti-inflammatory drugs in ocular inflammation. Int Ophthalmol Clin. 1996;36:195-206.
    • (1996) Int Ophthalmol Clin , vol.36 , pp. 195-206
    • Samiy, N.1    Foster, C.S.2
  • 11
    • 0036143229 scopus 로고    scopus 로고
    • Topical nonsteroidal anti-inflammatory drugs in ophthalmology
    • Flach AJ. Topical nonsteroidal anti-inflammatory drugs in ophthalmology. Int Ophtalmol Clin. 2002;42:1-11.
    • (2002) Int Ophtalmol Clin , vol.42 , pp. 1-11
    • Flach, A.J.1
  • 12
    • 0024463731 scopus 로고
    • Transport mechanisms of the cornea: Characterization of barrier permselectivity
    • Rojanasakul Y, Robinson JR. Transport mechanisms of the cornea: characterization of barrier permselectivity. Int J Pharm. 1989;55:237-246.
    • (1989) Int J Pharm , vol.55 , pp. 237-246
    • Rojanasakul, Y.1    Robinson, J.R.2
  • 13
    • 0037280734 scopus 로고    scopus 로고
    • Topical nonsteroidal anti-inflammatory therapy in ophthalmology
    • Schalnus R. Topical nonsteroidal anti-inflammatory therapy in ophthalmology. Ophthalmologica. 2003;217:89-98.
    • (2003) Ophthalmologica , vol.217 , pp. 89-98
    • Schalnus, R.1
  • 14
    • 0030871003 scopus 로고    scopus 로고
    • Effect of concentration, pH and preservatives on in vitro transcorneal permeation of ibuprofen and flurbiprofen from non-buffered aqueous drops
    • Gupta M, Majumdar DK. Effect of concentration, pH and preservatives on in vitro transcorneal permeation of ibuprofen and flurbiprofen from non-buffered aqueous drops. Indian J Exp Biol. 1997;35:844-849.
    • (1997) Indian J Exp Biol , vol.35 , pp. 844-849
    • Gupta, M.1    Majumdar, D.K.2
  • 15
    • 33846138667 scopus 로고    scopus 로고
    • Effect of formulation factors on in vitro permeation of diclofenac from experimental and marketed aqueous eye drops through excised goat cornea
    • Ahuja M, Dhake AS, Majumdar DK. Effect of formulation factors on in vitro permeation of diclofenac from experimental and marketed aqueous eye drops through excised goat cornea. Yakugaku Zasshi. 2006;126:1369-1375.
    • (2006) Yakugaku Zasshi , vol.126 , pp. 1369-1375
    • Ahuja, M.1    Dhake, A.S.2    Majumdar, D.K.3
  • 16
    • 77953460810 scopus 로고    scopus 로고
    • Voltaren Ophthalma® diclofenac, package insert, Duluth, GA: Novartis Ophthalmics; 2003
    • Voltaren Ophthalma® (diclofenac) [package insert]. Duluth, GA: Novartis Ophthalmics; 2003.
  • 17
    • 77953447051 scopus 로고    scopus 로고
    • Acular® ketorolac, package insert, Irvine, CA: Allergan Inc; 2002
    • Acular® (ketorolac) [package insert]. Irvine, CA: Allergan Inc; 2002.
  • 18
    • 77953376695 scopus 로고    scopus 로고
    • Nevanac® nepafenac, package insert, Fort Worth: Alcon Laboratories; 2005
    • Nevanac® (nepafenac) [package insert]. Fort Worth: Alcon Laboratories; 2005.
  • 19
    • 77953376130 scopus 로고    scopus 로고
    • Xibrom® bromfenac, package insert, Irvine, CA: ISTA Pharmaceuticals, Inc; 2006
    • Xibrom® (bromfenac) [package insert]. Irvine, CA: ISTA Pharmaceuticals, Inc; 2006.
  • 20
    • 22744455811 scopus 로고    scopus 로고
    • Emerging guidelines for the use of NSAID therapy to optimize cataract surgery and patient care
    • O'Brien TP. Emerging guidelines for the use of NSAID therapy to optimize cataract surgery and patient care. Curr Med Res Opin. 2005;21:1131-1137.
    • (2005) Curr Med Res Opin , vol.21 , pp. 1131-1137
    • O'Brien, T.P.1
  • 21
    • 0033757470 scopus 로고    scopus 로고
    • Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema
    • Heier JS, Topping TM, Baumann W, et al. Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema. Ophthalmology. 2000;107:2034-2039.
    • (2000) Ophthalmology , vol.107 , pp. 2034-2039
    • Heier, J.S.1    Topping, T.M.2    Baumann, W.3
  • 22
    • 0029024917 scopus 로고
    • A comparison of topical dicolfenac with prednisolone for postcataract inflammation
    • Roberts CW, Brennan KM. A comparison of topical dicolfenac with prednisolone for postcataract inflammation. Arch Ophthal. 1995;113:725-727.
    • (1995) Arch Ophthal , vol.113 , pp. 725-727
    • Roberts, C.W.1    Brennan, K.M.2
  • 23
    • 0031846811 scopus 로고    scopus 로고
    • A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells
    • El-Harazi SM, Ruiz RS, Feldman RM, et al. A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells. Ophthalmic Surg Lasers. 1998;29:539-544.
    • (1998) Ophthalmic Surg Lasers , vol.29 , pp. 539-544
    • El-Harazi, S.M.1    Ruiz, R.S.2    Feldman, R.M.3
  • 24
    • 0002734554 scopus 로고
    • Nonsteroidal anti-inflammatory drugs
    • Tasman W, editor, Philadelphia PA, Lippincott;
    • Flach AJ. Nonsteroidal anti-inflammatory drugs. In: Tasman W, editor. Duane's foundations of clinical ophthalmology. Philadelphia (PA): Lippincott; 1994. p. 1-32.
    • (1994) Duane's foundations of clinical ophthalmology , pp. 1-32
    • Flach, A.J.1
  • 25
    • 34548132382 scopus 로고    scopus 로고
    • Incidence of visually significant pseudophakic macular edema after uneventful phacoemulsification in patients treated with nepafenac
    • Sep;
    • Wolf EJ, Braunstein A, Shih C, Braunstein RE. Incidence of visually significant pseudophakic macular edema after uneventful phacoemulsification in patients treated with nepafenac. J Cataract Refract Surg. 2007 Sep; 33(9):1546-1549.
    • (2007) J Cataract Refract Surg , vol.33 , Issue.9 , pp. 1546-1549
    • Wolf, E.J.1    Braunstein, A.2    Shih, C.3    Braunstein, R.E.4
  • 26
    • 0344520471 scopus 로고    scopus 로고
    • Histopathology of corneal melting associated with diclofenac use after refractive surgery
    • Hsu JK, Johnston WT, Read RW, et al. Histopathology of corneal melting associated with diclofenac use after refractive surgery. J Cataract Refract Surg. 2003;29:250-256.
    • (2003) J Cataract Refract Surg , vol.29 , pp. 250-256
    • Hsu, J.K.1    Johnston, W.T.2    Read, R.W.3
  • 27
    • 0034041303 scopus 로고    scopus 로고
    • Nepafenac a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In vitro bioactivation and permeation of external ocular barriers
    • Ke T-L, Graff G, Spellman JM, Yanni JM. Nepafenac a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In vitro bioactivation and permeation of external ocular barriers. Inflammation. 2000;24:371-384.
    • (2000) Inflammation , vol.24 , pp. 371-384
    • Ke, T.-L.1    Graff, G.2    Spellman, J.M.3    Yanni, J.M.4
  • 28
    • 0000466265 scopus 로고    scopus 로고
    • Muscarinic receptor agonists and antagonists
    • Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, editors, 9th ed. New York: McGraw-Hill;
    • Brown HB, Taylor P. Muscarinic receptor agonists and antagonists. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, editors. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York: McGraw-Hill; 1996. p. 141-160.
    • (1996) Goodman and Gilman's The Pharmacological Basis of Therapeutics , pp. 141-160
    • Brown, H.B.1    Taylor, P.2
  • 29
    • 0023230366 scopus 로고
    • The analgesic and antiinflammatory activity and pharmacologic properties of bromfenac
    • Sancilio LF, Nolan JC, Wagner LE, Ward JW. The analgesic and antiinflammatory activity and pharmacologic properties of bromfenac. Arzneimittelforschung. 1987;37:513-519.
    • (1987) Arzneimittelforschung , vol.37 , pp. 513-519
    • Sancilio, L.F.1    Nolan, J.C.2    Wagner, L.E.3    Ward, J.W.4
  • 30
    • 0021733791 scopus 로고
    • Antiinflammatory agents. 3. Synthesis and pharmacological evaluation of 2-amino-3-benzoylpheylacetic acid and analogues
    • Walsh DA, Moran HW, Shamblee DA, et al. Antiinflammatory agents. 3. Synthesis and pharmacological evaluation of 2-amino-3-benzoylpheylacetic acid and analogues. J Med Chem. 1984;27:1379-1388.
    • (1984) J Med Chem , vol.27 , pp. 1379-1388
    • Walsh, D.A.1    Moran, H.W.2    Shamblee, D.A.3
  • 31
    • 77953411110 scopus 로고    scopus 로고
    • Data on file. ISTA Pharmaceuticals, Inc
    • Data on file. ISTA Pharmaceuticals, Inc.
  • 32
    • 33745685717 scopus 로고    scopus 로고
    • Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium
    • Waterbury LD, Silliman D, Jolas T. Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium. Curr Med Res Opin. 2006;22:1133-1140.
    • (2006) Curr Med Res Opin , vol.22 , pp. 1133-1140
    • Waterbury, L.D.1    Silliman, D.2    Jolas, T.3
  • 33
    • 77953414493 scopus 로고    scopus 로고
    • Yanni JM, Graff G, Hellberg MR. Topically administrable compositions containing 3-benzoylphenylaceteic acid derivatives for treatment of ophthalmic inflammatory disorders. Alcon Laboratories, Inc., assignee. US Patent 5,475,034. December 12, 1995.
    • Yanni JM, Graff G, Hellberg MR. Topically administrable compositions containing 3-benzoylphenylaceteic acid derivatives for treatment of ophthalmic inflammatory disorders. Alcon Laboratories, Inc., assignee. US Patent 5,475,034. December 12, 1995.
  • 34
    • 33750312737 scopus 로고    scopus 로고
    • Pharmacokinetic profile of topically applied bromfenac sodium ophthalmic sodium ophthalmic solution 0.1% in subjects undergoing cataract surgery
    • Ft. Lauderdale, FL, April 30-May 4
    • Ogawa T, Miyake K, McNamara TR, et al. Pharmacokinetic profile of topically applied bromfenac sodium ophthalmic sodium ophthalmic solution 0.1% in subjects undergoing cataract surgery. Proceedings of the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, Ft. Lauderdale, FL, April 30-May 4, 2006. A687.
    • (2006) Proceedings of the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
    • Ogawa, T.1    Miyake, K.2    McNamara, T.R.3
  • 36
    • 48349101855 scopus 로고    scopus 로고
    • Use of non-steroidal anti-inflammatory agents in combination with compounds that have PF prostaglandin agonist activity to treat glaucoma and ocular hypertension. Alcon Laboratories, Inc., assignee
    • US Patent 6,342,524 B1. January 29, 2002
    • Helberg MR, Nixon JC. Use of non-steroidal anti-inflammatory agents in combination with compounds that have PF prostaglandin agonist activity to treat glaucoma and ocular hypertension. Alcon Laboratories, Inc., assignee. US Patent 6,342,524 B1. January 29, 2002.
    • Helberg, M.R.1    Nixon, J.C.2
  • 38
    • 33750332012 scopus 로고    scopus 로고
    • Effect of bromfenac sodium ophthalmic solution on inflammation following intraocular lens implantation
    • Masuda K, Fukado Y, Shimizu H, et al. Effect of bromfenac sodium ophthalmic solution on inflammation following intraocular lens implantation. Ganka Rinsho Iho (Jpn Rec Vin Ophthalmol). 1997;91:745-750.
    • (1997) Ganka Rinsho Iho (Jpn Rec Vin Ophthalmol) , vol.91 , pp. 745-750
    • Masuda, K.1    Fukado, Y.2    Shimizu, H.3
  • 39
    • 34548142929 scopus 로고    scopus 로고
    • In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac
    • Walters T, Raizman M, Ernest P, Gayton J, Lehmann R. In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac. J Cataract Refract Surg. 2007;33(9): 1539-1545.
    • (2007) J Cataract Refract Surg , vol.33 , Issue.9 , pp. 1539-1545
    • Walters, T.1    Raizman, M.2    Ernest, P.3    Gayton, J.4    Lehmann, R.5
  • 40
    • 49449087916 scopus 로고    scopus 로고
    • Comparison of ketorolac 0.4% and bromfenac 0.09% at trough dosing: Aqueous drug absorption and prostaglandin E2 levels
    • Bucci F, Waterbury D. Comparison of ketorolac 0.4% and bromfenac 0.09% at trough dosing: Aqueous drug absorption and prostaglandin E2 levels. J Cataract Refract Surg. 2008;34:1509-1512.
    • (2008) J Cataract Refract Surg , vol.34 , pp. 1509-1512
    • Bucci, F.1    Waterbury, D.2
  • 41
    • 0037594952 scopus 로고    scopus 로고
    • Effect of bromfenac ophthalmic solution on ocular inflammation and corneal epithelial barrier function following cataract surgery
    • Kawaguchi T, Kida T, Nemoto S, et al. Effect of bromfenac ophthalmic solution on ocular inflammation and corneal epithelial barrier function following cataract surgery. Folia Ophthalmol Jpn. 2003;54:276-279.
    • (2003) Folia Ophthalmol Jpn , vol.54 , pp. 276-279
    • Kawaguchi, T.1    Kida, T.2    Nemoto, S.3
  • 42
    • 0042031376 scopus 로고    scopus 로고
    • Efficacy and adverse effects of bromfenac ophthalmic solution following cataract surgery
    • Takamatsu F, Shiroyama N, Saito Y, et al. Efficacy and adverse effects of bromfenac ophthalmic solution following cataract surgery. Rinsho Ganka (Jpn J Clin Ophthalmol). 2003;57:1233-1237.
    • (2003) Rinsho Ganka (Jpn J Clin Ophthalmol) , vol.57 , pp. 1233-1237
    • Takamatsu, F.1    Shiroyama, N.2    Saito, Y.3
  • 43
    • 33750375109 scopus 로고    scopus 로고
    • Effect of bromfenac sodium on postoperative inflammation
    • Ohara K, Ohkuba A, Miyamoto T, et al. Effect of bromfenac sodium on postoperative inflammation. Jpn J Catarac Refract Surg. 2004;18:1-12.
    • (2004) Jpn J Catarac Refract Surg , vol.18 , pp. 1-12
    • Ohara, K.1    Ohkuba, A.2    Miyamoto, T.3
  • 44
    • 34548224212 scopus 로고    scopus 로고
    • Bromfenac Ophthalmic Solution 0.09% (Xibrom) Study Group. Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation
    • Donnenfeld ED, Holland EJ, Stewart RH, Gow JA, Grillone LR; Bromfenac Ophthalmic Solution 0.09% (Xibrom) Study Group. Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation. Ophthalmology. 2007;114(9):1653-1662.
    • (2007) Ophthalmology , vol.114 , Issue.9 , pp. 1653-1662
    • Donnenfeld, E.D.1    Holland, E.J.2    Stewart, R.H.3    Gow, J.A.4    Grillone, L.R.5
  • 45
    • 36749092907 scopus 로고    scopus 로고
    • Bromfenac Ophthalmic Solution 0.09% Study Group. The systemic safety of bromfenac ophthalmic solution 0.09%
    • Stewart RH, Grillone LR, Shiffman ML, Donnenfeld ED, Gow JA; Bromfenac Ophthalmic Solution 0.09% Study Group. The systemic safety of bromfenac ophthalmic solution 0.09%. J Ocul Pharmacol Ther. 2007;23(6):601-612.
    • (2007) J Ocul Pharmacol Ther , vol.23 , Issue.6 , pp. 601-612
    • Stewart, R.H.1    Grillone, L.R.2    Shiffman, M.L.3    Donnenfeld, E.D.4    Gow, J.A.5
  • 46
    • 0035139998 scopus 로고    scopus 로고
    • Inadvertent diclofenac rechallenge from generic and non-generic prescribing, leading to liver transplantation for fulminant liver failure
    • Greaves RR, Agarwal A, Patch D, et al. Inadvertent diclofenac rechallenge from generic and non-generic prescribing, leading to liver transplantation for fulminant liver failure. Eur J Gastroenterol Hepatol. 2001;13:71-73.
    • (2001) Eur J Gastroenterol Hepatol , vol.13 , pp. 71-73
    • Greaves, R.R.1    Agarwal, A.2    Patch, D.3
  • 47
    • 8844264504 scopus 로고    scopus 로고
    • Diclofenac-induced liver injury: A paradigm of idiosyncratic drug toxicity
    • Aithal GP. Diclofenac-induced liver injury: A paradigm of idiosyncratic drug toxicity. Exp Opin Drug Saf. 2004;3:519-523.
    • (2004) Exp Opin Drug Saf , vol.3 , pp. 519-523
    • Aithal, G.P.1
  • 48
    • 0035696994 scopus 로고    scopus 로고
    • Ketorolac in the era of cyclo-oxygenase-2 selective nonsteroidal anti-inflammatory drugs: A systematic review of efficacy, side effects, and regulatory issues
    • Macario A, Lipman AG. Ketorolac in the era of cyclo-oxygenase-2 selective nonsteroidal anti-inflammatory drugs: A systematic review of efficacy, side effects, and regulatory issues. Pain Med. 2001;2:336-351.
    • (2001) Pain Med , vol.2 , pp. 336-351
    • Macario, A.1    Lipman, A.G.2
  • 49
    • 77953389944 scopus 로고    scopus 로고
    • Marked contralateral activity of bromfenac in a rabbit model of ocular inflammation
    • 46: Abstract 3936
    • Waterbury LD. Marked contralateral activity of bromfenac in a rabbit model of ocular inflammation. Invest Ophthalmol Vis Sci. 2005;46: Abstract 3936.
    • (2005) Invest Ophthalmol Vis Sci
    • Waterbury, L.D.1
  • 50
    • 77953463896 scopus 로고    scopus 로고
    • National PBM Drug Monograph, Xibrom® June 2006. Available from
    • National PBM Drug Monograph, Bromfenac 0.09% Ophthalmic Solution (Xibrom®) June 2006. Available from: http://www.pbm. va.gov/monograph/ Bromfenac0.09PercentOphthalmicSolution.pdf.
    • 09% Ophthalmic Solution
    • Bromfenac 01
  • 51
    • 0033871205 scopus 로고    scopus 로고
    • Corneal melting associated with use of topical nonsteroidal anti-inflammatory drugs after ocular surgery
    • Lin JC, Rapuano CJ, Laibson PR, et al. Corneal melting associated with use of topical nonsteroidal anti-inflammatory drugs after ocular surgery. Arch Ophthalmol. 2000;118:1129-1132.
    • (2000) Arch Ophthalmol , vol.118 , pp. 1129-1132
    • Lin, J.C.1    Rapuano, C.J.2    Laibson, P.R.3
  • 52
    • 0035320753 scopus 로고    scopus 로고
    • Corneal complications associated with topical ophthalmic use of nonsteroidal anti-inflammatory drugs
    • Congdon NG, Schein OD, von Kulajta P, et al. Corneal complications associated with topical ophthalmic use of nonsteroidal anti-inflammatory drugs. J Cataract Refract Surg. 2001;27:622-631.
    • (2001) J Cataract Refract Surg , vol.27 , pp. 622-631
    • Congdon, N.G.1    Schein, O.D.2    von Kulajta, P.3
  • 53
    • 0035747718 scopus 로고    scopus 로고
    • Corneal melts associated with topically applied nonsteroidal anti-inflammatory drugs
    • Flach AJ. Corneal melts associated with topically applied nonsteroidal anti-inflammatory drugs. Trans Am Ophthamol Soc. 2001; 99:205-212.
    • (2001) Trans Am Ophthamol Soc , vol.99 , pp. 205-212
    • Flach, A.J.1
  • 54
    • 0035029473 scopus 로고    scopus 로고
    • Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs
    • Guidera AC, Luchs JI, Udell IJ. Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs. Ophthalmology. 2001;108:936-944.
    • (2001) Ophthalmology , vol.108 , pp. 936-944
    • Guidera, A.C.1    Luchs, J.I.2    Udell, I.J.3
  • 55
    • 33644836124 scopus 로고    scopus 로고
    • Corneal ulceration and perforation with ketorolac tromethamine (Acular) use after PRK
    • Mian SI, Gupta A, Pineda R II. Corneal ulceration and perforation with ketorolac tromethamine (Acular) use after PRK. Cornea. 2006; 25:232-234.
    • (2006) Cornea , vol.25 , pp. 232-234
    • Mian, S.I.1    Gupta, A.2    Pineda II, R.3
  • 57
    • 33644839861 scopus 로고    scopus 로고
    • Three cases of corneal melting after instillation of a new nonsteroidal anti-inflammatory drug
    • Asai T, Nakagami T, Mochizuki M, et al. Three cases of corneal melting after instillation of a new nonsteroidal anti-inflammatory drug. Cornea. 2006;25:224-227.
    • (2006) Cornea , vol.25 , pp. 224-227
    • Asai, T.1    Nakagami, T.2    Mochizuki, M.3
  • 58
    • 34548043245 scopus 로고    scopus 로고
    • Corneal melting and perforation in Stevens Johnson syndrome following topical bromfenac use
    • Isawi H, Dhaliwal DK. Corneal melting and perforation in Stevens Johnson syndrome following topical bromfenac use. J Cataract Refract Surg. 2007;33(9):1644-1646.
    • (2007) J Cataract Refract Surg , vol.33 , Issue.9 , pp. 1644-1646
    • Isawi, H.1    Dhaliwal, D.K.2
  • 59
    • 0034828166 scopus 로고    scopus 로고
    • Effects of anti-inflammatory drugs on migration of the rabbit corneal epithelium
    • Hashizume N, Saika S, Okada Y, et al. Effects of anti-inflammatory drugs on migration of the rabbit corneal epithelium. J Cataract Rrefract Surg. 2001;27:1499-1502.
    • (2001) J Cataract Rrefract Surg , vol.27 , pp. 1499-1502
    • Hashizume, N.1    Saika, S.2    Okada, Y.3
  • 60
    • 0025357296 scopus 로고
    • Topical nonsteroidal agents and corneal would healing
    • Hersh PS, Rice BA, Baer JC, et al. Topical nonsteroidal agents and corneal would healing. Arch Ophthalmol. 1990;108:577-583.
    • (1990) Arch Ophthalmol , vol.108 , pp. 577-583
    • Hersh, P.S.1    Rice, B.A.2    Baer, J.C.3
  • 61
    • 33750312736 scopus 로고    scopus 로고
    • Postmarketing surveillance of bromfenac sodium (Bronuck) ophthalmic solution
    • Kitao, N, Shimoji, H, Fukuda M. Postmarketing surveillance of bromfenac sodium (Bronuck) ophthalmic solution. Jn Eye. 2005;22:1299-1308.
    • (2005) Jn Eye , vol.22 , pp. 1299-1308
    • Kitao, N.1    Shimoji, H.2    Fukuda, M.3
  • 62
    • 0036782635 scopus 로고    scopus 로고
    • Causes of non-compliance with drug regimens in glaucoma patients: A qualitative study
    • Taylor SA, Galbraith SM, Mills RP. Causes of non-compliance with drug regimens in glaucoma patients: a qualitative study. J Ocul Pharmacol Ther. 2002;18:401-409.
    • (2002) J Ocul Pharmacol Ther , vol.18 , pp. 401-409
    • Taylor, S.A.1    Galbraith, S.M.2    Mills, R.P.3
  • 63
    • 0028997927 scopus 로고
    • Compliance in subjects prescribed eye drops for glaucoma
    • Patel SC, Spaeth GL. Compliance in subjects prescribed eye drops for glaucoma. Ophthalmic Surg. 1995;26:233-236.
    • (1995) Ophthalmic Surg , vol.26 , pp. 233-236
    • Patel, S.C.1    Spaeth, G.L.2
  • 64
    • 2442585595 scopus 로고    scopus 로고
    • Corneal epithelial cellular dysfunction from benzalkonium chloride (BAC) in vitro
    • Cha SH, Lee JS, Oum BS, Kim CD. Corneal epithelial cellular dysfunction from benzalkonium chloride (BAC) in vitro. Clin Experiment Ophthalmol. 2004;32:180-184.
    • (2004) Clin Experiment Ophthalmol , vol.32 , pp. 180-184
    • Cha, S.H.1    Lee, J.S.2    Oum, B.S.3    Kim, C.D.4
  • 65
    • 0026515404 scopus 로고
    • Cyclo-oxygenase inhibitors in ophthalmology
    • Jan-Feb;
    • Flach AJ. Cyclo-oxygenase inhibitors in ophthalmology. Surv Ophthalmol. 1992 Jan-Feb; 36(4):259-284.
    • (1992) Surv Ophthalmol , vol.36 , Issue.4 , pp. 259-284
    • Flach, A.J.1
  • 66
    • 0032412542 scopus 로고    scopus 로고
    • The incidence, pathogenesis, and treatment of cystoids macular edema following cataract surgery
    • Flach AJ. The incidence, pathogenesis, and treatment of cystoids macular edema following cataract surgery. Trans Am Ophthalmol Soc. 1998;96:557-634.
    • (1998) Trans Am Ophthalmol Soc , vol.96 , pp. 557-634
    • Flach, A.J.1
  • 67
    • 0029690691 scopus 로고    scopus 로고
    • Cystoid macular edema
    • Quinn CJ: Cystoid macular edema. Optom Clin. 1996;5(1):111-130.
    • (1996) Optom Clin , vol.5 , Issue.1 , pp. 111-130
    • Quinn, C.J.1
  • 69
    • 34249934861 scopus 로고    scopus 로고
    • The role of NSAIDs in the management of postoperative ophthalmic inflammation
    • Colin J. The role of NSAIDs in the management of postoperative ophthalmic inflammation. Drugs. 2007;67(9):1291-1308.
    • (2007) Drugs , vol.67 , Issue.9 , pp. 1291-1308
    • Colin, J.1
  • 70
    • 0029863756 scopus 로고    scopus 로고
    • Pretreatment with topical diclofenac sodium to decrease postoperative inflammation
    • Roberts CW: Pretreatment with topical diclofenac sodium to decrease postoperative inflammation. Ophthalmology. 1996;103:636-639.
    • (1996) Ophthalmology , vol.103 , pp. 636-639
    • Roberts, C.W.1
  • 71
    • 0036770421 scopus 로고    scopus 로고
    • Pseudophakic macular edema
    • Ray S, D'Amico DJ. Pseudophakic macular edema. Semin Ophthalmol. 2002;17:167-180.
    • (2002) Semin Ophthalmol , vol.17 , pp. 167-180
    • Ray, S.1    D'Amico, D.J.2
  • 72
    • 0032693316 scopus 로고    scopus 로고
    • Cystoid macular edema after phacoemulsification: Relationship to blood-aqueous barrier damage and visual acuity
    • Ursell PG, Spalton DJ, Whitcup SM, Nussenblatt RB. Cystoid macular edema after phacoemulsification: relationship to blood-aqueous barrier damage and visual acuity. J Cataract Refract Surg. 1999;25(11):1492-1497.
    • (1999) J Cataract Refract Surg , vol.25 , Issue.11 , pp. 1492-1497
    • Ursell, P.G.1    Spalton, D.J.2    Whitcup, S.M.3    Nussenblatt, R.B.4
  • 73
    • 0142227840 scopus 로고    scopus 로고
    • Incidence of cystoids macular edema after uncomplicated phacoemulsification
    • Mentes J, Erakgun T, Afrashi F, Kerci G. Incidence of cystoids macular edema after uncomplicated phacoemulsification. Ophthalmologica. 2003;217(6):408-412.
    • (2003) Ophthalmologica , vol.217 , Issue.6 , pp. 408-412
    • Mentes, J.1    Erakgun, T.2    Afrashi, F.3    Kerci, G.4
  • 74
    • 33846307416 scopus 로고    scopus 로고
    • Cystoid macular edema after phacoemulsification: Risk factors and effect on visual acuity
    • Gulkilik G, Kocabora S, Taskapili M, Engin G. Cystoid macular edema after phacoemulsification: risk factors and effect on visual acuity. Can J Ophthalmol. 2006;4:699-703.
    • (2006) Can J Ophthalmol , vol.4 , pp. 699-703
    • Gulkilik, G.1    Kocabora, S.2    Taskapili, M.3    Engin, G.4
  • 75
  • 76
    • 0017687337 scopus 로고
    • Prevention of cystoid macular edema after lens extraction by topical indomethacin (I). A preliminary report
    • Miyake K. Prevention of cystoid macular edema after lens extraction by topical indomethacin (I). A preliminary report. Graefes Arch Klin Exp Ophthalmol. 1977;203:81-88.
    • (1977) Graefes Arch Klin Exp Ophthalmol , vol.203 , pp. 81-88
    • Miyake, K.1
  • 77
    • 0023142793 scopus 로고
    • Effectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudophakic cystoid macular edema
    • Flach AJ, Dolan BJ, Irvine AR. Effectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudophakic cystoid macular edema. Am J Ophthalmol. 1987;103:479-486.
    • (1987) Am J Ophthalmol , vol.103 , pp. 479-486
    • Flach, A.J.1    Dolan, B.J.2    Irvine, A.R.3
  • 78
    • 33044507658 scopus 로고    scopus 로고
    • Efficacy of topical Voltaren in reducing the incidence of postoperative cystoid macular edema
    • McColgin AZ, Raizman MB. Efficacy of topical Voltaren in reducing the incidence of postoperative cystoid macular edema. Invest Ophthalmol Vis Sci. 1999;40(Suppl):289.
    • (1999) Invest Ophthalmol Vis Sci , vol.40 , Issue.SUPPL. , pp. 289
    • McColgin, A.Z.1    Raizman, M.B.2
  • 79
    • 77953387823 scopus 로고    scopus 로고
    • Gross JG. Xibrom (bromfenac) reduces cystoid macular edema associated with vein occlusions, macular epiretinal membrane, diabetic retinopathy and age related macular degeneration. Poster F-3 presented at: Annual Meeting of the Retina Society. September 27-30; Boston.
    • Gross JG. Xibrom (bromfenac) reduces cystoid macular edema associated with vein occlusions, macular epiretinal membrane, diabetic retinopathy and age related macular degeneration. Poster F-3 presented at: Annual Meeting of the Retina Society. September 27-30; Boston.
  • 80
    • 77953435371 scopus 로고    scopus 로고
    • Bromfenac 0.09% versus diclofenac sodium 0.1% verseus ketorolac tromethamine 0.5% in the treatment of acute pseudophakic cystoids macular edema: Diclofenac versus ketorolac
    • Ft. Lauderdale, FL, April 30-May 4
    • Rho DS, Soll SM, Markovitz BJ. Bromfenac 0.09% versus diclofenac sodium 0.1% verseus ketorolac tromethamine 0.5% in the treatment of acute pseudophakic cystoids macular edema: diclofenac versus ketorolac. Proceedings of the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, Ft. Lauderdale, FL, April 30-May 4, 2006. AF211.
    • (2006) Proceedings of the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
    • Rho, D.S.1    Soll, S.M.2    Markovitz, B.J.3
  • 81
    • 3242772245 scopus 로고    scopus 로고
    • Prevention of miosis during cataract surgery by topical bromfenac sodium
    • Ohara K, Ohkubo A, Miyamoto T, et al. Prevention of miosis during cataract surgery by topical bromfenac sodium. Rinsho Ganka (Jpn J Clin Ophthalmol). 2004;58:1325-1328.
    • (2004) Rinsho Ganka (Jpn J Clin Ophthalmol) , vol.58 , pp. 1325-1328
    • Ohara, K.1    Ohkubo, A.2    Miyamoto, T.3
  • 82
    • 12144264233 scopus 로고    scopus 로고
    • Comparision of 0.1% bromfenac sodium and 0.1% pemirolast potassium for the treatment of allergic conjunctivitis
    • Miyake-Kashima M, Takano Y, Tanaka M, et al. Comparision of 0.1% bromfenac sodium and 0.1% pemirolast potassium for the treatment of allergic conjunctivitis. Jpn J Ophthalmol. 2004;48:587-590.
    • (2004) Jpn J Ophthalmol , vol.48 , pp. 587-590
    • Miyake-Kashima, M.1    Takano, Y.2    Tanaka, M.3
  • 83
    • 33750289768 scopus 로고    scopus 로고
    • Effect of bromfenac sodium (AHR-10282B) eye drops on anterior uveitis. Ganka Rinsho Iho (J Rev
    • Usui M, Masuda K. Effect of bromfenac sodium (AHR-10282B) eye drops on anterior uveitis. Ganka Rinsho Iho (J Rev Clin Ophthalmol). 1997;91:39-44.
    • (1997) Clin Ophthalmol , vol.91 , pp. 39-44
    • Usui, M.1    Masuda, K.2
  • 84
    • 0035833502 scopus 로고    scopus 로고
    • The coxibs, selective inhibitors of cyclooxygenase-2
    • FitzGerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med. 2001;345(6):433-442.
    • (2001) N Engl J Med , vol.345 , Issue.6 , pp. 433-442
    • FitzGerald, G.A.1    Patrono, C.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.